Which of the following drug used in the Management of Pulmonary Hypeension acts by inhibiting Phosphodiesterase enzyme?
**Core Concept**
Phosphodiesterase type 5 (PDE5) inhibitors are a class of medications that play a crucial role in the management of pulmonary hypertension. These drugs work by inhibiting the action of PDE5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a key signaling molecule involved in smooth muscle relaxation.
**Why the Correct Answer is Right**
Sildenafil, a PDE5 inhibitor, acts by increasing the levels of cGMP in the smooth muscle cells of the pulmonary arteries, leading to vasodilation and a subsequent decrease in pulmonary artery pressure. This mechanism is particularly beneficial in patients with pulmonary hypertension, as it helps to reduce the workload on the right heart and improve exercise tolerance. The increased levels of cGMP also lead to the relaxation of vascular smooth muscle, which in turn reduces pulmonary vascular resistance.
**Why Each Wrong Option is Incorrect**
**Option A:** Epoprostenol is a prostacyclin analog that acts as a vasodilator and is used in the management of pulmonary hypertension. However, it does not inhibit phosphodiesterase enzyme.
**Option B:** Bosentan is an endothelin receptor antagonist that is used to treat pulmonary hypertension. It works by blocking the action of endothelin-1, a potent vasoconstrictor, but it does not inhibit phosphodiesterase enzyme.
**Option C:** Nifedipine is a calcium channel blocker that is used to treat hypertension and angina. It works by inhibiting the influx of calcium ions into smooth muscle cells, leading to vasodilation. However, it does not inhibit phosphodiesterase enzyme.
**Clinical Pearl / High-Yield Fact**
PDE5 inhibitors, such as sildenafil, are also used in the treatment of erectile dysfunction. The mechanism of action is similar, with increased levels of cGMP leading to smooth muscle relaxation and vasodilation.
**✓ Correct Answer: D. Sildenafil**